SSRP1 and colorectal carcinoma: In addition, miR-28-5p expression was also decreased in drug-resistant CRC cells, thereby attenuating the inhibitory effect on downstream structure-specific recognition protein-1 (SSRP1) and increasing its expression to promote EMT by activating the Wnt/β-catenin pathway (45).